Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Shenouda Maged
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   197,403    

Indirect Shares

  0      
Direct Value   $112,953    

Indirect Value

  $0      
Total Shares   197,403      
Total Value   $112,953      


Relmada Therapeutics, Inc.
 $104,709 Protea Biosciences Group Inc
 $0 First Wave Biopharma Ord Shs
 $8,244 Relmada Therapeutics, Inc.
 $104,709 Protea Biosciences Group Inc
 $0 First Wave Biopharma Ord Shs
 $8,244
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    3   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    3   
    0    
   
     Gain/Loss Ratio :
   -3.0   
   0.0   
     Percentage Gain/Loss :
   -21.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Relmada Therapeutics, Inc. RLMD Chief Financial Officer 2024-01-31 34,903 2015-12-14 0    Premium*  
            Protea Biosciences Group Inc PRGB Director 2015-12-18 100,000 2015-12-18 0    Premium*  
            First Wave Biopharma Ord Shs FWBI 2018-12-28 62,500 0    Premium*  
* Premium Members only  

Records found :    31         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-02-24 4 AS $33.74 $102,529 D/D (3,000) 2,228 0 %
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-02-02 4 AS $35.04 $108,634 D/D (3,100) 2,328 0 %
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-02-08 4 AS $35.04 $126,242 D/D (3,603) 9,997 0 %
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-02-09 4 AS $35.24 $188,843 D/D (5,359) 4,638 0 %
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-03-09 4 AS $35.42 $267,693 D/D (7,527) 4,601 0 %
RLMD Relmada Therapeutics, Inc... CFO   •       –      –    2021-01-22 4 OE $324.00 $1,296,000 D/D 4,000 6,228 0 -

  31  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed